Cognizant acquires Zenith to become single source provider
Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.
Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.
Reconfigurable cleanroom pods to be used at Merck’s formulation laboratory to address increasing demands of diverse patient populations.
Kenneth Frazier argues that the current market dynamics are bringing treatments to patients and the industry does not ‘have to apologise for that.’